Article thumbnail
Location of Repository

Release kinetics of VEGF165 from a collagen matrix and structural matrix changes in a circulation model

By Johannes Kleinheinz, Susanne Jung, Kai Wermker, Carsten Fischer and Ulrich Joos
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2913915
Provided by: PubMed Central

Suggested articles

Citations

  1. (1999). Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart. Microvasc res
  2. (1997). Angiogenesis: a dynamic balance of stimulators and inhibitors. Thrombosis and Haemostasis
  3. (1996). Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively. Genomics
  4. (2005). Biological approaches to bone regeneration by gene therapy.
  5. (1987). Biology of bone transplantation. Orthop Clin North Am
  6. (1994). Bone and cartilage differentiation. Curr Opin Gen Develop
  7. (1990). Cartilage begets bone versus endochondral myeloporests. Clin Orthop
  8. (1996). Clinical evidence of angiogenesis after gene transfer of phVEGF165 in patient with ischemic limb. Lancet
  9. (1989). Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science
  10. (1998). Experimental reconstruction of the mandible using polylactic acid tubes and basic fibroblast growth factor in alloplastic scaffolds. J Oral Maxillofac Surg
  11. (1989). Filling cysts with type 1 bone collagen. Dtsch Zahnarztl Z
  12. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature
  13. (1993). HF: Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev
  14. (1997). KH: Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res
  15. (1995). Little CD: Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.
  16. (1998). Matrix and carrier for bone growth factors: state of the art and future perspectives.
  17. (1991). Mullem P: Biodegradation of four calcium phosphate ceramics; in vivo rates and tissue interactions.
  18. (1997). Osteoinduktion und -reparation. Mund Kiefer GesichtsChir
  19. (1998). Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
  20. (1994). Risau W: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol
  21. (1996). Sato K: Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res
  22. (1999). Serum concentration of VEGF and bFGF in patients with sagittal split ramus osteotomy. Int J Oral Maxillofac Surg
  23. (1995). Swoboda H: Die Bedeutung matrixgebundener Zytokine für die Osteoinduktion und Osteogenese. Implantologie
  24. (1996). The integrated process of hard tissue regeneration with special emphasis on fracture healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  25. (1998). Typ-I-Kollagen im xenogenen Knochenmaterial reguliert Anbindung und Verbreitung von Osteoblasten über die β1-Integrin-Untereinheit. Orthopäde
  26. (1999). Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res
  27. (1991). West D: Angiogenesis in wound healing. Pharm Ther

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.